Kruglova Ts 1

1. ASIA syndrome masked as recurrent angioedema: сan development be predicted by genetic screening (pilot study)
2. Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression moderate
3. Recurrent angioedema with normal C1-inhibitor: genetics determine the endotype
4. Artificial intelligence tools for phenotyping patients with anaphylaxis
5. Clinical and anamnestic analysis of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis hospitalised in Moscow. Development of a prognostic model of unfavourable outcomes
1